Plasma levels of IL-7 and IL-15 in the first month after myeloablative BMT are predictive biomarkers of both acute GVHD and relapse

IL-15 trans-presentation promotes human NK cell development and differentiation in vivo

Nicholas D. Huntington, Nicolas Legrand, Nuno L. Alves et al. · The Journal of Experimental Medicine · 2008 · 563 citations · Full text

Life Sciences, Cell Biology, Immunology +17

Administration of rhIL-7 in humans increases in vivo TCR repertoire diversity by preferential expansion of naive T cell subsets

Claude Sportès, Frances T. Hakim, Sarfraz Memon et al. · The Journal of Experimental Medicine · 2008 · 467 citations · Full text

Life Sciences, Immunology, Clinical Immunology +16

Allogeneic Marrow Stem-Cell Transplantation From Human Leukocyte Antigen–Identical Siblings Versus Human Leukocyte Antigen–Allelic–Matched Unrelated Donors (10/10) in Patients With Standard-Risk Hematologic Malignancy: A Prospective Study From the French Society of Bone Marrow Transplantation and Cell Therapy

Ibrahim Yakoub‐Agha, Florence Mesnil, Mathieu Kuentz et al. · Journal of Clinical Oncology · 2006 · 267 citations · Full text

Medicine, Hematology, Immunology +17

Serum levels of IL-7 in bone marrow transplant recipients: relationship to clinical characteristics and lymphocyte count

Ellen Bolotin, Geralyn Annett, Robertson Parkman et al. · Bone Marrow Transplantation · 1999 · 216 citations

Life Sciences, Hematology, Immunology +8

Rapid natural killer cell recovery determines outcome after T-cell-depleted HLA-identical stem cell transplantation in patients with myeloid leukemias but not with acute lymphoblastic leukemia

Bipin N. Savani, Stephan Mielke, Sharon Adams et al. · Leukemia · 2007 · 183 citations

Life Sciences, Hematology, Immunology +17